Valuation: Frontage Holdings Corporation

Market Cap 243M 1.91B 213M 196M 183M 345M 22.98B 353M 2.36B 913M 11.34B 913M 893M 39.35B P/E 2026 *
29.4x
P/E 2027 * 16x
Enterprise Value 251M 1.97B 220M 203M 190M 357M 23.77B 365M 2.45B 944M 11.73B 944M 923M 40.71B EV / Sales 2026 *
0.88x
EV / Sales 2027 * 0.89x
Free-Float
26.5%
Yield 2026 *
-
Yield 2027 * -
1 day+1.06%
1 week-3.06%
Current month+35.71%
1 month+31.94%
3 months-13.64%
6 months-6.86%
Current year-5.00%
1 week 0.81
Extreme 0.81
1
1 month 0.68
Extreme 0.68
1.15
Current year 0.68
Extreme 0.68
1.16
1 year 0.68
Extreme 0.68
1.87
3 years 0.47
Extreme 0.47
2.58
5 years 0.47
Extreme 0.47
8.97
10 years 0.47
Extreme 0.47
9.18
Manager TitleAgeSince
Chief Executive Officer 57 2025-01-05
Chief Executive Officer 62 2025-01-05
Director of Finance/CFO 41 2025-07-14
Director TitleAgeSince
Director/Board Member 67 2018-04-16
Director/Board Member 62 -
Director/Board Member 57 2018-03-31
Date Insider Type Main position Quantity % Market Cap.
24-10-29Other

Chief Executive Officer

4,500,000 0.2211%
24-10-29Other

Founder

4,500,000 0.2211%
24-01-25Other

Chief Executive Officer

179,582 0.0087%
Change 5-day change 1-year change 3-year change Capi.($)
+1.06%-3.06%-11.21%-52.50% 243M
+0.83%+5.75%-3.58%+2.14% 46.62B
+5.79%+16.17%+421.86%+634.63% 40.95B
+1.12%+15.18%+22.74%-12.71% 32.26B
+3.61%+6.69%+20.23%+62.38% 32.24B
+8.02%+6.35%+17.67%+34.73% 25.53B
+1.13%+15.66% - - 16.38B
+1.45%+17.35%+72.11%+127.60% 15.27B
-0.06%+4.45%+12.74%+17.16% 13.61B
-0.60%+6.32%+102.74%+96.28% 13.34B
Average +2.23%+9.82%+72.81%+101.08% 23.64B
Weighted average by Cap. +2.80%+11.57%+98.10%+145.55%

Financials

2026 *2027 *
Net sales 286M 2.24B 250M 231M 216M 406M 27.02B 415M 2.78B 1.07B 13.33B 1.07B 1.05B 46.28B 312M 2.45B 273M 252M 236M 444M 29.51B 454M 3.04B 1.17B 14.56B 1.17B 1.15B 50.55B
Net income 8.5M 66.65M 7.44M 6.87M 6.41M 12.08M 803M 12.35M 82.66M 31.91M 396M 31.91M 31.21M 1.38B 10.85M 85.12M 9.5M 8.77M 8.19M 15.42M 1.03B 15.77M 106M 40.76M 506M 40.76M 39.86M 1.76B
Net Debt 8.39M 65.77M 7.34M 6.78M 6.33M 11.92M 793M 12.19M 81.57M 31.49M 391M 31.49M 30.8M 1.36B 33.35M 262M 29.2M 26.96M 25.17M 47.39M 3.15B 48.46M 324M 125M 1.56B 125M 122M 5.4B
Logo Frontage Holdings Corporation
Frontage Holdings Corporation is a holding company. It provides laboratory and related services to pharmaceutical and agrochemical companies, as well as bioequivalence clinical and chemical services. The Company has two main divisions: Global Laboratory Services and Global Drug Discovery & Development Services. The Global Laboratory Services division offers laboratory testing support for clients involved in drug development. The Global Drug Discovery & Development Services division includes Drug Development Unit, the Drug Discovery Unit, and the Pharmaceutical Product Development Unit. Its Global Laboratory Services encompass regulated and non-regulated bioanalysis (both small and large molecules), biomarkers, genomics, manufacturing and controls analytical testing, and central laboratory services. The Drug Development Unit includes drug metabolism and pharmacokinetics, Safety and Toxicology. The Company's segments include North America and Europe and PRC.
Employees
1,523
Date Price Change Volume
26-06-30 HK$0.9500 +1.06% 156,000
26-06-29 HK$0.9400 +9.30% 162,000
26-06-26 HK$0.8600 -11.34% 632,000
26-06-25 HK$0.9700 -1.02% 6,000
26-06-24 HK$0.9800 0.00% 154,000
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
0.1199USD
Average target price
0.1240USD
Spread / Average Target
+3.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1521 Stock